Treatment outcomes of oxaliplatin, 5-FU, and leucovorin as salvage therapy for patients with advanced or metastatic gastric cancer: A retrospective analysis

Cancer Chemotherapy and Pharmacology

Volumn 63, Issue 3, 2009, Pages 433-439

  Seo, Hee Yeon ^a   Kim, Dae Sik ^a   Choi, Yoon Seok ^a   Sung, Hwa Jung ^a   Park, Kyong Hwa ^a   Choi, In Keun ^a   Kim, Seok Jin ^a   Oh, Sang Cheul ^a   Seo, Jae Hong ^a   Choi, Chul Won ^a   Kim, Byung Soo ^a   Shin, Sang Won ^a   Kim, Yeul Hong ^a   Kim, Jun Suk ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

5 Fluorouracil; Gastric cancer; Oxaliplatin; Salvage therapy

Indexed keywords

CISPLATIN; DOCETAXEL; EPIRUBICIN; FLUOROURACIL; FOLINIC ACID; MITOMYCIN; OXALIPLATIN; ANTINEOPLASTIC AGENT; PLATINUM COMPLEX;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CONTINUOUS INFUSION; CONTROLLED STUDY; DERMATITIS; DIARRHEA; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; OVERALL SURVIVAL; PARESTHESIA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SALVAGE THERAPY; STOMACH CANCER; STOMATITIS; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT OUTCOME; VOMITING; MIDDLE AGED; PATHOLOGY; STOMACH TUMOR; SURVIVAL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; NEOPLASM METASTASIS; ORGANOPLATINUM COMPOUNDS; RETROSPECTIVE STUDIES; SALVAGE THERAPY; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 58249142779     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-008-0753-3     Document Type: Article

References (29)

1. HR Shin YJ Won KW Jung 2005 Nationwide cancer incidence in Korea, 1999-2001; first result using the national cancer incidence database Cancer Res Treat 37 325 331
2. R Epelbaum N Haim M Stein Y Cohen E Robinson 1987 Treatment of advanced gastric cancer with DDP (cisplatin), adriamycin, and 5-fluorouracil (DAF) Oncology 44 201 206 (Pubitemid 17117518)
3. M Lopez L Di Lauro P Papaldo EM Conti 1986 Treatment of advanced measurable gastric carcinoma with 5-fluorouracil, adriamycin, and BCNU Oncology 43 288 291 (Pubitemid 16054044)
4. Y Becouarn C Agostini N Trufflandier V Boulanger 2001 Oxaliplatin: available data in non-colorectal gastrointestinal malignancies Crit Rev Oncol Hematol 40 265 272 (Pubitemid 33111071)
5. E Raymond S Faivre JM Woynarowski SG Chaney 1998 Oxaliplatin: mechanism of action and antineoplastic activity Semin Oncol 25 4 12 (Pubitemid 28248696)
6. C Kollmannsberger O Rick HG Derigs 2002 Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study Group J Clin Oncol 20 2031 2037 (Pubitemid 34408792)
7. JM Extra M Espie F Calvo C Ferme L Mignot M Marty 1990 Phase I study of oxaliplatin in patients with advanced cancer Cancer Chemother Pharmacol 25 299 303 (Pubitemid 20014976)
8. M Degardin P Cappelaere I Krakowski P Fargeot D Cupissol S Brienza 1996 Phase II trial of oxaliplatin (L-OHP) in advanced, recurrent and/or metastatic squamous cell carcinoma of the head and neck Eur J Cancer B Oral Oncol 32B 278 279 (Pubitemid 26246315)
9. C Louvet T Andre G Lledo 2002 Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II study J Clin Oncol 20 1512 1518 (Pubitemid 34260530)
10. I Monnet S Brienza F Hugret 1998 Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer (NSCLC). ATTIT. Association pour le Traitement des Tumeurs Intra Thoraciques Eur J Cancer 34 1124 1127
11. T Andre MA Bensmaine C Louvet 1999 Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen J Clin Oncol 17 3560 3568 (Pubitemid 29517928)
12. E Raymond C Buquet-Fagot S Djelloul 1997 Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidylate synthase inhibitor AG337 in human colon, breast and ovarian cancers Anticancer Drugs 8 876 885 (Pubitemid 27487802)
13. SE Al-Batran A Atmaca S Hegewisch-Becker 2004 Phase II trial of biweekly infusional fluorouracil, folinic acid, and oxaliplatin in patients with advanced gastric cancer J Clin Oncol 22 658 663 (Pubitemid 41102130)
14. L Cavanna F Artioli C Codignola 2006 Oxaliplatin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in patients with metastatic gastric cancer (MGC) Am J Clin Oncol 29 371 375 (Pubitemid 44201990)
15. F De Vita M Orditura E Matano 2005 A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients Br J Cancer 92 1644 1649 (Pubitemid 40762627)
16. F Lordick S Lorenzen J Stollfuss 2005 Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer Br J Cancer 93 190 194 (Pubitemid 41135888)
17. C Louvet T Andre JM Tigaud 2002 Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients J Clin Oncol 20 4543 4548 (Pubitemid 35407422)
18. P Therasse SG Arbuck EA Eisenhauer 2000 New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 205 216
19. F Levi JL Misset S Brienza 1992 A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer Cancer 69 893 900
20. DM Parkin F Bray J Ferlay P Pisani 2005 Global cancer statistics, 2002 CA Cancer J Clin 55 74 108 (Pubitemid 40372904)
21. B Glimelius K Ekstrom K Hoffman 1997 Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer Ann Oncol 8 163 168 (Pubitemid 27112884)
22. DY Kim JH Kim SH Lee 2003 Phase II study of oxaliplatin, 5-fluorouracil and leucovorin in previously platinum-treated patients with advanced gastric cancer Ann Oncol 14 383 387 (Pubitemid 36367414)
23. Y Chao KH Yeh CJ Chang 2004 Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer Br J Cancer 91 453 458 (Pubitemid 39106839)
24. SY Oh HC Kwon BG Seo SH Kim JS Kim HJ Kim 2007 A phase II study of oxaliplatin with low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) as first line therapy for patients with advanced gastric cancer Acta Oncol 46 336 341 (Pubitemid 46628612)
25. SG Kim SY Oh HC Kwon 2007 A phase II study of irinotecan with bi-weekly, low-dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFIRI) as salvage therapy for patients with advanced or metastatic gastric cancer Jpn J Clin Oncol 37 744 749 (Pubitemid 350123351)
26. S Ueda S Hironaka N Boku A Fukutomi T Yoshino Y Onozawa 2006 Combination chemotherapy with irinotecan and cisplatin in pretreated patients with unresectable or recurrent gastric cancer Gastric Cancer 9 203 207 (Pubitemid 44426894)
27. SH Park EY Choi SM Bang 2005 Salvage chemotherapy with irinotecan and cisplatin in patients with metastatic gastric cancer failing both 5-fluorouracil and taxanes Anticancer Drugs 16 621 625 (Pubitemid 40867293)
28. ST Kim WK Kang JH Kang 2005 Salvage chemotherapy with irinotecan, 5-fluorouracil and leucovorin for taxane- and cisplatin-refractory, metastatic gastric cancer Br J Cancer 92 1850 1854 (Pubitemid 40826132)
29. JL Lee MH Ryu HM Chang 2008 A phase II study of docetaxel as salvage chemotherapy in advanced gastric cancer after failure of fluoropyrimidine and platinum combination chemotherapy Cancer Chemother Pharmacol 61 631 637